The global mexoryl SX (ecamsule) market was valued at $49.5 million in 2021, and is projected to reach $82.6 million by 2031, growing at a CAGR of 5.3% from 2022 to 2031.
Mexoryl SX is the trade name for ecamsule, or terephthalylidene dicamphor sulfonic acid. It is an organic sun filter (carbon-based) developed and patented by L'Oréal in 1982. It protects mainly against UVA rays, the main cause of premature skin aging and skin cancers. In addition, it is used as a photostable drug that resists the formation of UV induced pyrimidine dimers and delays the onset of skin cancer.
The increasing awareness toward skincare, beauty, and lifestyle has surged the demand for personal care & cosmetic products where mexoryl SX (ecamsule) protects skin mainly from long wave ultraviolet A (UVA) rays that is the main cause of premature skin aging and skin cancers. This may propel the growth of the mexoryl SX) ecamsule) market. In addition, rise in concerns about skin protection against detrimental rays of the sun and improved alertness regarding skin cancer have led the customers become more linear toward using mexoryl SX (ecamsule)-based sunscreens, which fosters the growth of the mexoryl SX (ecamsule) market.
However, mexoryl SX (ecamsule) is a newly developed product and is relatively new in the market. It requires certain testing and approvals for its adoption among various end use applications. For instance, food and drug administration (FDA) is proposing to prevent the use of ecamsule and anzacamene in sunscreens due to their ineffectiveness. Thus, FDA’s action means that Americans may not have access to these products. This factor may hamper the growth of the mexoryl SX (ecamsule) market during the forecast period.
On the contrary, surge in R&D activities for developing a broad spectrum of sunscreens formulation where mexoryl SX (ecamsule) is widely used for photo-protection purposes in all skin types may create new opportunities for the market.
The mexoryl SX (ecamsule) market is segmented into purity level, application, and region. On the basis of purity level, the market is segregated into less than 98% and more than 98%. Depending on application, it is fragmented into cosmetics, phamraceuticals, and others. Region wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.
The leading players operating in the global mexoryl SX (ecamsule) market include Biosynth Carbosynth, ChemScene LLC, Derma Company, National Analytical Corporation, Norna Technology Co., Skylead Pharmaceuticals & Chemicals, L'Oréal S.A., and MFCI CO.,LTD (Hubei Meifeng Chemical Co., Ltd.). The global mexoryl SX (ecamsule) market report provides in-depth competitive analysis as well as profiles of these major players.
Mexoryl SX is the trade name for ecamsule, or terephthalylidene dicamphor sulfonic acid. It is an organic sun filter (carbon-based) developed and patented by L'Oréal in 1982. It protects mainly against UVA rays, the main cause of premature skin aging and skin cancers. In addition, it is used as a photostable drug that resists the formation of UV induced pyrimidine dimers and delays the onset of skin cancer.
The increasing awareness toward skincare, beauty, and lifestyle has surged the demand for personal care & cosmetic products where mexoryl SX (ecamsule) protects skin mainly from long wave ultraviolet A (UVA) rays that is the main cause of premature skin aging and skin cancers. This may propel the growth of the mexoryl SX) ecamsule) market. In addition, rise in concerns about skin protection against detrimental rays of the sun and improved alertness regarding skin cancer have led the customers become more linear toward using mexoryl SX (ecamsule)-based sunscreens, which fosters the growth of the mexoryl SX (ecamsule) market.
However, mexoryl SX (ecamsule) is a newly developed product and is relatively new in the market. It requires certain testing and approvals for its adoption among various end use applications. For instance, food and drug administration (FDA) is proposing to prevent the use of ecamsule and anzacamene in sunscreens due to their ineffectiveness. Thus, FDA’s action means that Americans may not have access to these products. This factor may hamper the growth of the mexoryl SX (ecamsule) market during the forecast period.
On the contrary, surge in R&D activities for developing a broad spectrum of sunscreens formulation where mexoryl SX (ecamsule) is widely used for photo-protection purposes in all skin types may create new opportunities for the market.
The mexoryl SX (ecamsule) market is segmented into purity level, application, and region. On the basis of purity level, the market is segregated into less than 98% and more than 98%. Depending on application, it is fragmented into cosmetics, phamraceuticals, and others. Region wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.
The leading players operating in the global mexoryl SX (ecamsule) market include Biosynth Carbosynth, ChemScene LLC, Derma Company, National Analytical Corporation, Norna Technology Co., Skylead Pharmaceuticals & Chemicals, L'Oréal S.A., and MFCI CO.,LTD (Hubei Meifeng Chemical Co., Ltd.). The global mexoryl SX (ecamsule) market report provides in-depth competitive analysis as well as profiles of these major players.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the mexoryl sx (ecamsule) market analysis from 2021 to 2031 to identify the prevailing mexoryl sx (ecamsule) market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the mexoryl sx (ecamsule) market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global mexoryl sx (ecamsule) market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Purity Level
- Less than 98%
- More than 98%
By Application
- Cosmetics
- Pharmaceuticals
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Australia
- Rest of Asia-Pacific
- China
- India
- Japan
- South Korea
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- L'Oréal S.A.
- Skylead Pharmaceuticals & Chemicals
- ChemScene LLC
- Biosynth Carbosynth
- NATIONAL ANALYTICAL CORPORATION
- Norna Technology Co.
- Derma Companies
- MFCI CO.,LTD
- Merck KGaA
- Parchem Fine and Specialty Chemicals
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL
CHAPTER 5: MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION
CHAPTER 6: MEXORYL SX (ECAMSULE) MARKET, BY REGION
CHAPTER 7: COMPANY LANDSCAPE
CHAPTER 8: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report, titled, “Mexoryl SX (Ecamsule) Market," the mexoryl sx (ecamsule) market was valued at $49.5 million in 2021, and is estimated to reach $82.6 million by 2031, growing at a CAGR of 5.3% from 2022 to 2031.Mexoryl SX (Ecamsule) is an organic compound that is added to many sunscreens to filter out UVA rays. It possesses excellent photostability, which makes it best-suited for use as an active ingredient in manufacturing anti-ageing creams, long ultraviolet (UVA) ray absorbers, sunscreens, and anti-skin cancer drugs.
The rise in concerns about skin protection against detrimental rays of the sun and improved alertness regarding skin cancer have led the customers become more linear toward using Mexoryl SX (Ecamsule)-based sunscreens. According to a report published by the Indian Ministry of Economy and Industry, the personal care and cosmetics industry is one of the fastest-growing sectors and was worth around $10.5 million in 2021. In addition, incidence of both non-melanoma and melanoma skin cancers has been increasing over the past decades where mexoryl SX (ecamsule) is widely used to produce anti-skin cancer drugs. For instance, according to a report published by the World Health Organization (WHO), around 2-3 million cases of non-melanoma skin cancers and 132,000 cases of melanoma skin cancers occur globally each year. This is anticipated to foster the demand for mexoryl (SX) ecamsule market during the forecast period.
However, lack of awareness among customers about the benefits of mexoryl SX (Ecamsule) may restrain the growth of the mexoryl SX (Ecamsule) market during the forecast period.
On the contrary, rise in R&D activities for developing a broad spectrum of sunscreens formulation where mexoryl SX (ecamsule) is widely used for photo-protection purposes in all skin types may create new opportunities for the market.
The mexoryl (SX) ecamsule market is segmented on the basis of purity level, application, and region. By purity level, the market is segregated into less than 98% and more than 98%. The more than 98% segment dominated the global market in terms of revenue in 2021, with 68.08% of the total share. This is attributed to the increasing incidence of both non-melanoma and melanoma skin cancers. Mexoryl SX (ecamsule) with more than 98% purity levels is widely used to produce anti-skin cancer drugs. This has surged the popularity of mexoryl (SX) ecamsule with more than 98% purity levels among the pharmaceutical sector.
By application, the market is divided into cosmetics, pharmaceuticals, and others. The cosmetics segment dominated the global market in terms of revenue in 2021, with 71.92% of the total share. This is attributed to rising concerns about skin protection against detrimental rays of the sun and improved alertness regarding skin cancer have led the customers become more linear toward using mexoryl SX (ecamsule)-based sunscreens and other cosmetic formulations. This factor may fuel the demand for mexoryl (SX) ecamsule for cosmetics applications.
Region-wise, the mexoryl (SX) ecamsule market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The Europe mexoryl (SX) ecamsule market size is projected to grow at the highest CAGR during the forecast period, owing to increasing proportion of elder population in countries such as Italy and Spain, which in turn has surged the demand for anti-ageing creams where mexoryl SX (ecamsule) acts as an active ingredient in manufacturing various anti-ageing formulations. For instance, according to a report published by Population Reference Bureau, Italy ranks second in world’s oldest populations (aged 65 and above) with 23% of the population with age 65 and above. This factor has augmented the growth of the mexoryl (SX) ecamsule market in the Europe region.
Key players operating in the global mexoryl (SX) ecamsule market include Biosynth Carbosynth, ChemScene LLC, Derma Company, National Analytical Corporation, Norna Technology Co., Skylead Pharmaceuticals & Chemicals, L'Oréal S.A., and MFCI CO., LTD (Hubei Meifeng Chemical Co., Ltd.).
COVID-19 Analysis
- The novel coronavirus is an incomparable global pandemic that has spread to over 180 countries and caused huge losses of lives and the economy around the globe. The mexoryl SX (ecamsule) market has little impact due to the wake of the COVID-19 pandemic, owing to the disruptions in the supply chain for various personal hygiene, and medical products. Furthermore, to control the surge of novel coronavirus cases, there is a drastic shift of investments from other sectors toward healthcare. Moreover, several ecamsule manufacturing companies have either shut down or shrank their operations due to the risk of infection among the workforce. This has temporarily hampered the demand and supply chain of air-laid products amid the COVID-19 pandemic. However, growth in awareness related to personal care activities has surged the demand for mexoryl SX (ecamsule)-based sunscreens, anti-ageing creams, and other cosmetic products during the COVID-19 pandemic, which in turn has increased the demand for mexoryl SX (ecamsule) market. Furthermore, several ecamsule manufacturing companies have adopted safety strategies and techniques, which in turn may increase the demand for air-laid product as the market starts stabilizing.
- In 2020, mexoryl SX (ecamsule) prices were higher in Asia-Pacific. The price rise was, due to continued regional demand trends and tight product availability. Firm downstream air-laid product’s demand and stronger upstream costs are expected to sustain the price gain.
- However, the mexoryl SX (ecamsule) market is expected to recover rapidly post COVID-19 situation due to its increased dependency over pharmaceutical other sectors. For instance, according to an article published by Financial Express, the Indian pharmaceutical industry registered a growth of 15% in 2021, and is expected to grow at an average annual growth rate of 18.6% by 2025. This is expected to enhance the performance of the mexoryl SX (ecamsule) post- COVID-19 scenario.
Key Findings of the Study
- By purity level, the more than 98% segment is estimated to display the highest growth rate, in terms of revenue, registering a CAGR of 5.4% from 2022 to 2031.
- By application, the cosmetics segment is estimated to display the highest growth rate, in terms of revenue, registering a CAGR of 5.4% from 2022 to 2031.
- North America garnered the highest share of 32.93% in 2021, in terms of revenue, growing at a CAGR of 5.2%.
Companies Mentioned
- L'oréal S.A.
- Skylead Pharmaceuticals & Chemicals
- Chemscene LLC
- Biosynth Carbosynth
- National Analytical Corporation
- Norna Technology Co.
- Derma Companies
- Mfci Co.Ltd
- Merck Kgaa
- Parchem Fine and Specialty Chemicals
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 199 |
| Published | July 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 49.5 million |
| Forecasted Market Value ( USD | $ 82.6 million |
| Compound Annual Growth Rate | 5.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
